Skip to main content
. 2021 Dec 29;2021:7967552. doi: 10.1155/2021/7967552

Table 2.

Study participants' (n = 40) demographic and clinical characteristics.

Characteristics Participants (n = 40)
Gender
 M 23 (58%)
Occupation
 Working 17 (42%)
 Retired 13 (33%)
 Handicapped 10 (25%)
Chemotherapy
 5FU 17 (42%)
 Xeloda 23 (58%)
Median (IQR)
Age 58 (53, 67)
Tumor stage 3 (3, 3)
Number of treatments 28 (23, 33)
BMI 27.5 (23.6, 30.1)
Hemoglobin 11.8 (10.7, 13.2)

BMI = body mass index.